Search research articles
Contact Us
Filters
Showing results (171-180 of 234) with videos related to
Page
of 24
Sort By:
Urology
|
January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma
M A Carducci, S Piantadosi, C R Pound, et al.
Urology
|
November 17, 2001
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
D A Barocas, M Han, J I Epstein, et al.
IEEE Transactions on Bio-Medical Engineering
|
November 4, 2000
In vivo measurement of tumor conductiveness with the magnetic bioimpedance method
D G Smith, S R Potter, B R Lee, et al.
Analytical and Quantitative Cytology and Histology
|
January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study
I Simon, P B Snow, L S Marks, et al.
Urology
|
February 1, 1997
Prostate-specific antigen in men born with bladder exstrophy
R I Silver, A W Partin, J I Epstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2013
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
M T Schweizer, X C Zhou, H Wang, et al.
The Journal of Urology
|
July 29, 1998
Influence of radical prostatectomy on serum hormone levels
L R Miller, A W Partin, D W Chan, et al.
The Journal of Urology
|
August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy
G S Bova, A W Partin, S D Isaacs, et al.
Prostate Cancer and Prostatic Diseases
|
August 11, 2004
Stromal-epithelial measurements of prostate cancer in native Japanese and Japanese-American men
R W Veltri, J Park, M C Miller, et al.
Urology
|
August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model
W J Catalona, A W Partin, J A Finlay, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 234) with videos related to
Sort By:
Page
of 24
Urology
|
January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma
M A Carducci, S Piantadosi, C R Pound, et al.
Urology
|
November 17, 2001
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
D A Barocas, M Han, J I Epstein, et al.
IEEE Transactions on Bio-Medical Engineering
|
November 4, 2000
In vivo measurement of tumor conductiveness with the magnetic bioimpedance method
D G Smith, S R Potter, B R Lee, et al.
Analytical and Quantitative Cytology and Histology
|
January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study
I Simon, P B Snow, L S Marks, et al.
Urology
|
February 1, 1997
Prostate-specific antigen in men born with bladder exstrophy
R I Silver, A W Partin, J I Epstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2013
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
M T Schweizer, X C Zhou, H Wang, et al.
The Journal of Urology
|
July 29, 1998
Influence of radical prostatectomy on serum hormone levels
L R Miller, A W Partin, D W Chan, et al.
The Journal of Urology
|
August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy
G S Bova, A W Partin, S D Isaacs, et al.
Prostate Cancer and Prostatic Diseases
|
August 11, 2004
Stromal-epithelial measurements of prostate cancer in native Japanese and Japanese-American men
R W Veltri, J Park, M C Miller, et al.
Urology
|
August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model
W J Catalona, A W Partin, J A Finlay, et al.
Page
of 24